Novo Nordisk's total assets for Q4 2025 were kr542.90B, an increase of 5.98% from the previous quarter. DE:NOVA total liabilities were kr348.86B for the fiscal quarter, a 1.89% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.